Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair.

Scotts Miracle-Gro CEO Nate Baxter Talks Growth Strategy
07:19

American Petroleum's Mike Sommers Talks Hormuz Oil Flows
08:18

Moelis & Co.'s Eric Cantor Talks AI Supercycle
07:44